Why does this Omega-3 primarily contain DHA and not EPA?Updated 10 days ago

DHA is central to brain structure and function
Docosahexaenoic acid (DHA) makes up about 90% of the brain’s omega‑3 content and roughly 10–15% of its total fatty acids. It is built directly into neuronal membranes, supporting fluidity, signaling, and neuroplasticity—key for cognitive development and healthy aging.

EPA’s benefits are less consistent—even for heart health
Eicosapentaenoic acid (EPA) is often cited for cardiovascular support and anti‑inflammatory action, yet large clinical trials and meta‑analyses show mixed results: some interventions (especially high‑dose purified EPA in high‑risk patients) improve certain outcomes, while many standard‑dose mixed EPA/DHA studies report neutral effects on cardiovascular events and no clear cognitive advantage.

Formulation that matches the evidence
Because DHA has the strongest and most consistent research basis for brain health—and EPA’s benefits, including cardiovascular, remain inconsistent at typical supplement doses—we prioritize DHA in our algal omega-3 formulation.